Coronary interventions

A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study

EuroIntervention 2015;11:541-548 published online ahead of print August 2014. DOI: 10.4244/EIJY14M08_06

Emanuele Barbato1, MD; Sonja Salinger-Martinovic2, MD; Dragan Sagic3, MD; Branko Beleslin4, MD; Mathias Vrolix5, MD; Aleksandar N. Neskovic6, MD; Nikola Jagic7, MD; Stefan Verheye8, MD; Zlatko Mehmedbegovic4, MD; William Wijns1*, MD

1. Cardiovascular Center Aalst, Aalst, Belgium; 2. Clinical Centre Nis, Nis, Serbia; 3. Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia; 4. Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 5. AZ St J

Aims: To report the six-month angiographic and two-year clinical outcome data from the first-in-man study with the Ultimaster DES, a thin-strut cobalt-chromium sirolimus-eluting stent (SE

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bioresorbable polymerclinical researchsirolimus

Share on Facebook Share on Twitter Share on Linkedin

A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study

Latest news